Supplementary appendix
PROLIA )دينوسوماب( لعالج هشاشة العظام لدى الرجال والسيدات
Supplementary appendix
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies | SpringerLink
Frontiers | Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Confidentiality Notice
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Hossam A Saad's research works | Amgen, CA and other places
Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization - ScienceDirect
Study design for the denosumab dose ranging trial and (b) resulting... | Download Scientific Diagram
Australian Public Assessment Report for Denosumab
PDF) Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization
Confidentiality Notice
Frontiers | Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies | SpringerLink
PDF) Predicting Nonlinear Changes in Bone Mineral Density Over Time Using a Multiscale Systems Pharmacology Model
Dynamics of Bone Cell Interactions and Differential Responses to PTH and Antibody-Based Therapies | SpringerLink
PDF) Effects of long-term treatment of denosumab on bone mineral density: insights from an in-silico model of bone mineralization
Perspective on the State of Pharmacometrics and Systems Pharmacology Integration - Trame - 2018 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Frontiers | Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
Patient Support Program Directory | IMD Health
